Discussion about preferred placed of death in patients diagnosed with AML, DLBCL and myeloma at the two HMRN study hospitals between May 2005 and April 2008 who died before May 2010, and congruence between preferred and actual place of death in those with a discussion (n=142)
| Actual place of death (N %) | |||||
|---|---|---|---|---|---|
| Total (N %) | Hospital | Home | Hospice | Nursing home | |
| All deaths | 323 (100) | 240 (74.3) | 49 (15.2) | 18 (5.6) | 16 (5.0) |
| Discussion about preferred place of death | |||||
| No | 181 (100) | 152 (84.0) | 15 (8.3) | 5 (2.8) | 9 (5.0) |
| Yes | 142 (100) | 88 (62.0) | 34 (23.9) | 13 (9.2) | 7 (4.9) |
| Preferred place of death | |||||
| Hospital | 40 (100) | 40 (100.0) | – | – | – |
| Home | 65 (100) | 31 (47.7) | 32 (49.2) | – | 2 (3.1) |
| Hospice | 24 (100) | 11 (45.8) | – | 13 (54.2) | – |
| Nursing home | 8 (100) | 3 (37.5) | – | – | 5 (62.5) |
| Undecided | 5 (100) | 3 (60.0) | 2 (40.0) | – | – |
Shaded area represents the number and proportion of patients who died in their preferred place.
AML, acute myeloid leukaemia; DLBCL, diffuse large B-cell lymphoma; HMRN, Haematological Malignancy Research Network.